Despite blocking a broad spectrum of Cullin–RING E3 ligases including CRL4DCAF1, NF2–NAE inhibitors could be a promising target for therapeutic intervention in patients with merlin-negative mesothelioma. Here, NF2 is linked to mesothelioma.